Back to Top

Information For Authors

Use of LanguageManuscript Types and Word LimitsSubmission ComponentsReference List PreparationManuscript Submission ProcessJournal PoliciesPeer Review  • Authorship •  Copyright, Licensing, and Open Access
Autism in Adulthood is published by Mary Ann Liebert, Inc. publishers, headquartered in New Rochelle, New York. The founding Editor-in-Chief is Christina Nicolaidis, MD, MPH. The Journal is managed by an academic chief editor, associate editors, and an international editorial board comprised of leading researchers, autistic community leaders, and practitioners focused on autism in adulthood.


All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

All manuscripts must be submitted through our online peer review site:



The language used to describe autism can greatly affect people on the spectrum, and how society views them. Autism in Adulthood recommends authors consider the following recommendations.


Autism in Adulthood respects that there are strong arguments and passions on both sides of the debate between the use of person-first language (e.g., “person with autism”) and identity-first language (e.g., “autistic person”) in relation to autism. However, there is a growing body of scientific and community literature documenting the dislike, amongst autistic individuals, of person-first language and its potential for increasing stigma.1-4 Based on this literature and the strong preference of the autistic members of the journal’s Editorial Board, we recommend either using identity-first language, or more neutral terms such as "person on the autism spectrum.”

  1. Gernsbacher MA. Editorial Perspective: The use of person-first language in scholarly writing may accentuate stigma. Journal of Child Psychology and Psychiatry. 2017;58(7):859-861.
  2. Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. Deficit, Difference, or Both? Autism and Neurodiversity. Developmental Psychology. 2013;49(1):59-71.
  3. Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E. Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2016;20(4):442-462.
  4. Sinclair J. Why I dislike "person first" language. 1999; November 21, 2017.


Due to the ambiguity and potential offensiveness of terms such as “high functioning” or “low functioning” autism, “Kanner's” autism, or "mild" or "severe" autism, Autism in Adulthood recommends avoiding these terms. Instead, describe subpopulations using the specific characteristic(s) that make them a subpopulation. For example, "autistic people who qualify for developmental disability services," or "autistic people who primarily communicate using speech."


The term “Autism Spectrum Disorder” (ASD) may be used when specifically discussing autism diagnoses. Otherwise, we recommend using terms such as “autism,” “autism spectrum,” “autistic adults,” or “autistic participants.” When referring to historic data, historic diagnoses such as Asperger's syndrome may be used; however, these terms should be considered out of date, and not used as terms for any part of the autism spectrum except when referring to someone’s self-identity.


Autism in Adulthood strongly encourages authors to take a strengths-based approach to writing about autism. Examples include:
•    Referring to autism as a condition or disability instead of as a disease or illness;
•    Using neutral terms such as "typically developing" or “non-autistic” rather than "healthy" or “normal;”
•    Avoiding emotional phrases such as "suffering from autism;"
•    Referring to “co-occurring” or “secondary” conditions instead of “comorbid” conditions;
•    Referring to autistic characteristics in a neutral or positive manner, as opposed to as symptoms or deficits (e.g. “autistic traits,” “characteristics of autism,” or “features of autism” instead of “symptoms of autism”; “communication differences” instead of “communication deficits”).


The National Center on Disability and Journalism maintains a comprehensive guide for writing about disability. It includes both how to talk about disability and how not to talk about disability. It is recommended that authors refer to this guide for answers to other specific or general questions (see
The Editors of Autism in Adulthood welcome questions by authors regarding language. We understand language can be a gray area, can vary by geography and culture, and that there are many valid opinions. Contact the Editor at for further guidance.


All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Autism in Adulthood. For authors whose native language is not English, we recommend using a service that will aid in the translation and rewriting of material into correct English usage. The Publisher offers this service for a fee prior to official submission. For more information, please contact: Please note that employing the use of the Publisher’s service is not required, and using it does not guarantee acceptance of any paper. All submissions are subject to peer review.


Autism in Adulthood recommends the use of the active voice as opposed to the passive voice. Further, we recommend the actor in a sentence always be explicitly identified for clarity. For example: “A research assistant administered the surveys.” (Not: “Surveys were administered.”) Autism in Adulthood also recommends use of clear, concise language. Avoid using sentences with excessive clauses or unnecessary complexity.



Manuscript Type


Word Limits**
for main text


Original Research

Descriptions of rigorously conducted empirical research studies

3000-word limit, except for qualitative studies, which can use up to 4000 words

Structured; 300-word maximum

Brief Research Report

Concise, focused reports about original research

1500-word limit; 2 tables or figures

Structured; 300-word maximum

Conceptual Analysis

Well-supported analytic essays advancing theory, practice, or policy

5000-word limit

Unstructured; 250-word maximum

Advances in Methodology

Evidence- or practice-based recommendations that advance research methods, processes, or approaches

5000-word limit

Unstructured; 250-word maximum

Emerging Practices

Well-referenced descriptions of innovative practices, grounded in theory, with lessons learned from their initial implementation or pilot-testing

3000-word limit

Unstructured; 250-word maximum

Literature Reviews and Meta-analyses 

Systematic reviews are preferred; however high-quality narrative, clinical, or scoping reviews are welcome for topics not conducive to systematic review

5000-word limit

Systematic and scoping reviews and meta-analyses – structured; 300-word maximum

Narrative or clinical reviews – unstructured; 250-word maximum


Well-referenced opinions or recommendations on topics related to research, practice, or policy.

3000-word limit

Unstructured; 250-word maximum


Personal memoir-like essays from autistic adults or other stakeholders that provide important insights for the field

2000-word limit

No abstract


Solicited by the Editor to accompany a manuscript to be published in Autism in Adulthood

1500-word limit

No abstract

Letter to the Editor

Letter in response to articles published in Autism in Adulthood

500-word limit, 4 references, and 1 table OR figure

No abstract

Reviews of books, media, and resources

Brief reviews of books, media, or other resources of relevance to autism in adulthood. Solicited by the Editors

1000 words (or greater at the discretion of the Editors)

No abstract

 **Word limits do NOT include the title, abstract, tables, figure legends, references, disclosures, or acknowledgments.


Autism in Adulthood may also publish other manuscript types at the discretion of the Editors. Contact to discuss ideas for possible manuscripts that do not fit these categories.


The main text should use the following headings: Introduction; Methods; Results; Discussion. The Discussion section should include (in the following order) a discussion of the study conclusions, how the study compares to and advances the existing literature, limitations, and implications (to individuals, practitioners, systems, policy, and/or research).
To ensure that studies with various methods have the highest quality reporting, Autism in Adulthood strongly suggests authors use standard formats as described at (i.e., CONSORT for randomized trials, STROBE for observational studies, and SQUIRE for quality improvement studies, etc.). Authors are strongly encouraged to use the checklists offered for these guidelines. The Editor(s) may request those checklists during the manuscript review process.
Clinical Trials Registration: Autism in Adulthood ascribes to the registration policies of the International Committee of Medical Journal Editors (ICMJE) that can be found at . Appropriate registries (such as must be accessible to the public at no charge and must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. Please include the appropriate Trial Registration Number on the Title Page of the submitted manuscript.


Autism in Adulthood welcomes well-supported, in-depth, analytic essays advancing theory, practice, or policy. Manuscripts should present a novel idea, develop a new conceptual theory or model, or synthesize the literature in an innovative way.


Advances in Methodology manuscripts focus on methodologic issues in research on autism in adulthood. This article type purposefully allows for flexibility in how manuscripts are structured, so that authors can best present information to advance the field. For example, manuscripts may describe the processes used in a research project and discuss lessons learned or they may make evidence- or practice-based recommendations for why different methods are needed. We welcome evidence- or practice-based guidelines that advance research methods, processes, or approaches. Such manuscripts should explain the need for the new guidelines; describe how the guidelines were developed, including the evidence base and/or practice experience that guided them; provide the guidelines; describe how they advance the literature; explain where they may or may not apply; and discuss their implications for research, practice, and policy.


Autism in Adulthood welcomes well-referenced descriptions of innovative practices, grounded in theory, with lessons learned from their initial implementation or pilot-testing. Manuscripts should be organized as follows:

1. Introduction (including why this emerging practice is needed)
2. Theoretical Framework (describing how the practice is grounded in the literature)
3. A description of the emerging practice, intervention, technology, or other advancement (note – authors may choose to name this section as appropriate)

4. Evaluation Methods
5. Lessons Learned (including evaluation data, observations from practice, and other lessons from initial implementation efforts)
6. Discussion (including conclusions, how this work advances the literature, limitations, implications, and next steps).


Whenever possible, Autism in Adulthood prefers systematic reviews, with or without a quantitative meta-analysis.

Systematic reviews and meta-analyses of quantitative evidence should follow the guidelines in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. PRISMA (an update and expansion of the QUOROM Statement) provides an evidence-based minimum set of items for reporting systematic reviews and meta-analyses. It can be found at . The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. Authors are strongly encouraged to submit the PRISMA checklist and flow diagram along with their manuscript. Although PRISMA focuses on randomized trials, the PRISMA Statement can also be used as a basis for reporting systematic reviews of other types of research. The Background section should describe study objectives. Methods should include eligibility criteria, information sources, and methods of assessing risk of bias. The Results section should report included studies, synthesis of results, and description of the effect. Finally, the Discussion should include strengths and limitations of the evidence. Also include the systematic review registration number and funding source.

Autism in Adulthood will consider inclusion of high-quality narrative or clinical reviews when the question of interest is too broad, the body of evidence too sparse, or the topic too new or controversial for a systematic review. Narrative (non-systematic) or clinical reviews should address a clinical, educational, services, policy, or methodological problem. They should meld expert opinion with a thorough and balanced review of available evidence. Reviews of clinical topics should include references to relevant practice guidelines. Scoping reviews may also be appropriate for topics where the literature is still relatively scant.


Perspectives are well-referenced opinions or recommendations on topics related to research, practice, or policy. Authors should heavily cite the literature to make a clear, coherent argument. They should be transparent about their own positionality, experience, and expertise. Perspectives must synthesize and advance the literature in a novel way, through the author(s) own lens(es), not solely review the current state of the science.


Autism in Adulthood welcomes personal memoir-like essays from autistic adults, family members, professionals, or other stakeholders. The essay should be written for an academic audience and use citations, if appropriate, but it should be in the author’s own voice. The author should use their personal experiences to provide insights to others in the field. Essays may be in a variety of formats, including, but not limited to first-person narratives, creative non-fiction, poetry, and graphics.



Submit a cover letter addressed to the Editor with each manuscript. Include a brief overview of the manuscript (including title, design, and major findings), and explain why the manuscript would be of interest to the readers of Autism in Adulthood and how it would impact the field. As appropriate, include additional information that would help the Editors place this study in the context of other work (e.g., if the manuscript describes one specific analysis from a larger study, explain how this manuscript fits in with other papers, where other papers have been published, and describe the stage of preparation of other planned manuscripts). If part of the manuscript information has been published previously, please indicate where it was published, and the extent of overlap with this manuscript. Attach a copy of the articles (or manuscripts) in question.
Autism in Adulthood encourages authors to provide the names and contact information for 3-5 appropriate potential reviewers who have no conflicts of interest with the manuscript (but provision of reviewer recommendations is not mandatory for submission). Reviewer selection is ultimately at the discretion of the Editor(s).  Autism in Adulthood uses a single-masked review process. As such, authors of the manuscript are identifiable to reviewers.


Please include a title page of your submission as part of your main text document (not as a separate file). It must include the following items:

•    The complete title of the article;
•    All contributing authors’ full names, complete affiliation information (if applicable), and email addresses;
•    A brief running title of no more than 45 characters, including spaces;
•    Denotation of the corresponding author and his/her complete contact information including address and email address;
•    If applicable, the study registry number;
•    Three (3) to six (6) manuscript keywords;

•    Include word count for abstract;

•    Include word count for main text; and

•    Include word count for lay summary.

Creating an Effective Title:

•    Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted.
•    Titles should be no more than 12-15 words. (Editors may grant exceptions in certain cases where a longer title is needed.) 

•    Titles should be direct and to the point. The journal has a global readership, so clear and concise non-vernacular language is most effective. 

•    Avoid the use of specific locations or regions in the title. 

•    Do not use proprietary/trademarked names in the title. 

•    Do not use acronyms in the title unless they are universally recognized and accepted. 

•    Avoid using the title to make declarative statements about results of the study.  For example, instead of “X is Related to Y in Autistic Adults,” use titles such as “The Association Between X and Y in Autistic Adults: Results from a Prospective Cohort Study.”

Keyword Search Terms

On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you select for the peer review process and areas of expertise. These keywords will be included in the published article.

AUTHORSHIP CONFIRMATION STATEMENT (See Authorship section for more information)

On a separate page within the manuscript file, following the title page, include a paragraph detailing each listed authors’ contributions to and responsibilities for the manuscript. This text should also contain a statement that all co-authors have reviewed and approved of the manuscript prior to submission. Lastly, include a confirmation statement that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere (posting on a non-peer-reviewed preprint server does not constitute prior publication).


On a separate page within the manuscript file, following the Authorship Confirmation Statement page, include any financial conflicts of interest, actual or potential, for each listed author on the submission. If no conflicts exist, the authors must state, “No competing financial interests exist.” Articles submitted without Author Disclosure Statements will be un-submitted so that a statement may be added.

*See the JOURNAL POLICIES section below for more information, or visit the ICJME website at


•     The abstract must be included as part the main text file, after the Author Confirmation Statement. Please see the table under Manuscript Types and Word Limits for information on whether the abstract
       should be structured or unstructured and for the abstract’s word limit.
•    Prepare the abstract on a separate page to be included after the title page and the Authorship Confirmation Statement page. References are not permitted in the abstract.
•    Do not use proprietary or trade names in the abstract.
•    For manuscript types requiring a structured abstract, use the following headings: Background, Methods, Results, and Conclusions.
•    For manuscript types requiring an unstructured abstract, the abstract should briefly summarize the background and rationale and clearly summarize the findings and/or conclusions of the work.


After the title page, Authorship Confirmation, and Author Disclosure Statements, and abstract, prepare the remainder of the text, as appropriate to the manuscript type (see additional information above under Manuscript types).

 After the main text of the manuscript, include the following sections:

•    Acknowledgments
•    References (information on formatting below)
•    Appendices (if applicable)


Prepare a lay-language summary, of up to 500 words, highlighting the most important aspects of the manuscript. This summary should be aimed at what the lay public, including autistic adults, family members, practitioners, services providers, and policymakers, would want to know about the manuscript. Please use Plain Language and avoid or define technical terms.

Lay summaries should use a question and answer format. Lay summaries for Original Research should use the following headers: “Why was this study done?” “What was the purpose of this study?” “What did the researchers do?” “What were the results of the study?” “What do these findings add to what was already known?” “What are potential weaknesses in the study?” and “How will these findings help autistic adults now or in the future?”

Authors may use different question headers for other article types. For example, a lay summary for an Emerging Practices manuscript may use headers such as: “Why was this program developed?” “What does the program do?” “How did the researchers evaluate the new program?” “What were the early findings?” “What were the weaknesses of this project?” ”What are the next steps?” and “How will this work help autistic adults now or in the future?”. Similarly, headers for a Perspectives manuscript may include: “Why is this topic important?” “What is the purpose of this article?” “What is the perspective of the author(s)?” “What is already known about this topic?” and “What do the authors recommend?” and “How will these recommendations help autistic adults now or in the future?”

For more information on Plain Language, please see: and


•    Prepare each figure as an individual .TIFF or .EPS file.
•    Do NOT submit figures in Word, PowerPoint, PDF, Bitmap, .JPEG, or Excel.
•    Line illustrations must be submitted at 900 DPI.
•    Halftones and color should be submitted at a minimum of 300 dpi.
•    Color art must be saved as CMYK - not RGB. (N.B., If RGB files are submitted, the files will be converted to CYMK and some color variation will occur in the print version of the article.)
•    Black and white art must be submitted as grayscale – not RGB.

To convert Word or Excel files into a format which is suitable for print by scanning them, use the below guidelines:

•    All files should be scanned at 100% size
•    At least 300 dpi
•    Final color mode: CMYK
•    Save file as: .tif, .tiff, or .eps

For more direction on how to convert a PowerPoint slide to acceptable format go to:

For color publication costs, see Journal Fees in the JOURNAL POLICIES section below.


•    Number tables consecutively
•    Include a table title for each numbered table.
•    Prepare all tables in one, single Word document (.doc or .docx), with each numbered table beginning on a new page.
•    Do not include tables in the main manuscript text file.
•    Do not embed tables within the text.
•    Use Arabic numerals to number tables.
•    Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
•    Define all acronyms used within the body of the table in table footnotes.
•    All other types of table footnotes should be designated using superscript letters, not symbols.
•    Name all table files in English and use only alphanumeric characters. Do not use symbols, dots, lines, or dashes.
•    Table file names should be formatted with first author’s last name and the word, "Tables". (Ex: SmithTables).
•    Upload one table file, containing all tables, under the “Table” file designation.  Be sure to number each table within the file.


When appropriate, we encourage the judicious use of online-only supplementary information (SI). Refer to all information/data in the SI in the article text, including reference to specific tables and figures in the SI. Upload supplementary tables, figures, and legends as separate files, either as “supplementary file” or “supplementary file for review only.” The paper that appears in the printed journal should contain all data which are key to the conclusions and important for the reader to have direct access to when reading the paper. Other supporting data and text are appropriate for the supplementary section.


Autism in Adulthood follows AMA style ( Prepare a numbered (not alphabetical) reference list, in the order of citation within text and double spaced, at the end of the text of the manuscript (do not upload the reference list as a separate file). See formatting examples below.


Cite all references appearing in the reference list in numerical order, as superscripted numbers (no parentheses) and outside sentence punctuation.

AMA style requires the use of standard abbreviations for all references, when applicable. Abbreviations of journal titles in reference section should follow the style of MEDLINE ( If a work is in press, state the journal title in which it is to be published, and include "in press" in parenthesis in place of a volume and page range. When references to unpublished sources/correspondence are used, supply the researcher’s name and date.


At this time, Autism in Adulthood does not yet have a template in EndNote, but you may use the journal JAMA as a substitute as it follows the same reference style. Go to, search for “JAMA” and download the template.**
**NOTE: The Publisher of Autism in Adulthood does not provide technical support for EndNote. If you have questions, click on the Support tab on EndNote’s website for assistance.


Journal Article:*†
Kanfiszer L, Davies F, Collins S. 'I was just so different': The experiences of women diagnosed with an autism spectrum disorder in adulthood in relation to gender and social relationships. Autism. 2017;21(6):661-669.

Siew CT, Mazzucchelli TG, Rooney R, Girdler S. A specialist peer mentoring program for university students on the autism spectrum: A pilot study. PLOS ONE. 2017;12(7):e0180854.

*Citations containing more than six authors should list the first three, followed by et al.
†The preferred citation style for an electronic journal uses a DOI (digital object identifier). The DOI provides a persistent link to the electronic item and is considered to be more stable than a URL. If the DOI is not given on the full text article or in the citation, use a DOI Lookup Tool ( to locate it or use the format for an electronic article without a DOI.

Wright SD, ed. Autism Spectrum Disorder in Mid and Later Life. Philadelphia, Pennsylvania: Jessica Kingsley Publishers; 2016.

Chapter in a Book:
Crapnell T, Lau L, Hanks CD, Nicolaidis C, Kuo AA. Autism. In: Pilapil M, DeLaet DE, Kuo AA, Peacock C, Sharma N, eds. Care of Adults with Chronic Childhood Conditions: A Practical Guide. Switzerland: Springer Internaltional Publishing; 2016;53–65.

Website: Please follow this structure for website references, including capitalization and punctuation:
List author (if available) and/or page name/title. Website article title. Provide website URL. Include last accessed date.

Conference Proceedings: Please follow this structure for Conference Proceeding references, including capitalization and punctuation:

List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials). Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.

Preprints may be cited in same manner as a journal article. Discretion is recommended as preprints are, by definition, not peer reviewed.


All manuscripts must be submitted through our online peer review site:


Submissions to Autism in Adulthood are managed through our online peer review system, Manuscript Central. If you do not already have an account in Manuscript Central specifically for Autism in Adulthood, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either already have an account, or have one created, in the system. Before creating an account for your coauthor(s), search the database using your coauthors’ email addresses to ascertain if an account already exists. If no account exists, you may create one on behalf of your coauthor(s). For technical assistance, contact


•    Name all files in English and use only alphanumeric characters. Do not use symbols, dots, lines, or dashes.
•    Files names should be formatted with first author’s last name and the content description number (Ex: SmithFig1; SmithTables; SmithTextFile).


Upload manuscript files to our system in the following order:

•    Cover letter
•    Manuscript/Main text file
•    Lay summary
•    Tables
•    Figure legends
•    Figures
•    Supplementary files

Note: There is a total limit of 200 MB per submission.


Review Keywords are areas of expertise to be used for peer review. 
While uploading your manuscript files, you will be asked to select 4-6 keywords from the drop-down list of pre-selected terms to facilitate the peer review process. These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.


Do NOT create a new submission for revisions of already-submitted manuscripts. Detailed instructions for submitting revised manuscripts are provided in an email which is sent to the corresponding author along with the reviewers’ comments. Revised submissions routinely undergo further review by the same reviewers who assessed the original submission, members of the editorial board, and/or the editor(s). Contact the Editorial Office immediately if the deadline for your revised submission has expired. Please note that an invitation to revise any submission does not guarantee acceptance.


All accepted manuscripts will go through copyediting, typesetting, figure sizing and placement, author proofing, corrections, revisions (from corrected proofs), online-ahead-of-print release, and lastly, issue assignment. Depending on the length and complexity of any accepted submission, these steps typically take 3-6 weeks from acceptance.


Page proofs will be sent to the corresponding author as designated when the manuscript was submitted. It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof. The Publisher will not accept corrections from multiple authors.


The corresponding author is responsible for returning corrected galley proofs within 72 hours of receipt. Only corrections directly related to errors in typesetting will be allowed; revisions to text are not permitted at this stage. Content changes require the approval of the Editor and may delay publication. If the corresponding author does not respond within the allotted timeframe, the manuscript may be delayed in the publication schedule, or published as is, at the discretion of the Editor and Publisher. If the corresponding author expects to be unavailable during the time the manuscript is in production, the publisher should be provided with an alternate contact.


Autism in Adulthood generally follows Committee on Publication Ethics (COPE; and International Committee of Journal Medical Editors (ICJME; guidelines.


Manuscripts must be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same or substantially similar form, except in the form of an abstract.


Autism in Adulthood recognizes the growing popularity of community non-peer-reviewed preprint repositories such as bioRxiv, arXiv, ChemRxiv, PeerJ Preprints, etc. Deposition of a preprint on a preprint server will not impact consideration of any manuscript submitted to Autism in Adulthood. The existence of a publicly available preprint should be declared upon submission.


Autism in Adulthood is a single-masked peer-reviewed journal. All submissions will undergo peer review to assess the scientific basis and significance of the manuscript. Two editors will read each manuscript and decide if it matches the journal’s scope, aims, and scientific standards. If it does, then they will send the manuscript for external peer review. Manuscripts sent for external review will be reviewed by two or more academic experts and at least one autistic adult. While sometimes, an autistic scholar may fill both roles, we expect the majority of autistic reviews to be by lay people. These autistic reviewers will help ensure that work published in Autism in Adulthood is relevant to the needs of the autistic community, uses respectful concepts and language, and includes lay summaries that are accessible to autistic adults, their families, and other stakeholders. Following peer review, the Editor and/or Associate Editors will determine if the paper should be accepted, require revision, or is unacceptable for publication.

Time in Review

The journal strives to maintain a short, but thorough peer-review process. The average time for an initial review is 21-30 days but the Editor strives to expedite manuscript handling, if circumstances allow.


Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Sharing a manuscript in whole or in part, outside the scope of what is necessary for assessment, is impermissible prior to the manuscript’s official publication date.


Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review, unless it violates the privacy or confidentiality of human research subjects.

Papers Authored by the Editor-in-Chief and/or Associate Editors, Deputy Editors, or Members of the Editorial Board.

The Editor-in-Chief, Associate Editors, Deputy Editors, and Editorial Board members will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest. This includes manuscripts submitted by close colleagues.



Patient Consent/Release

If applicable, it is incumbent upon the author(s) to obtain and preserve patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form.

Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.

In keeping with patients’ rights of privacy, the Journal does not collect the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests they have received and archived written patient consent, and that they are available upon request.


All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles, and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.


When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013 ( If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from internal review boards, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.
All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. (


Authorship, as defined by the International Committee of Medical Journal Editors, is based on the following criteria:

1.    Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2.    Drafting the work or revising it critically for important intellectual content; AND
3.    Final approval of the version to be published; AND
4.    Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
***Important Note about Author Listing***
It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. All authors’ names must be entered into the Journal’s submission site. Failure to properly list all contributing authors could result in delays in peer review or publication, and may cause other potential problems.


All authors are encouraged to complete their submissions using an ORCID identifier. Please visit the ORCID website ( for more information, or to register.


There is no limit of authors permitted on a single submission, but in cases where there are 20 or more co-authors, Autism in Adulthood recommends that a collective group or consortium name be provided and the individual authors and their affiliations listed in the Acknowledgments.


It is the Journal’s policy that a manuscript lists only one corresponding author. This designation should be determined at the time of submission. All communications regarding any submission, except for copyright forms, will be directed only to the corresponding author.
Working Groups/Team Authorship


It is permissible to list up to two authors as co-first authors. Include an asterisk (*) next to the authors’ names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, “These authors contributed equally to this work and are considered co-first authors.”


Working Groups or Teams may be listed in the manuscript byline, but the entire listing of names should be included in the Acknowledgment section of the manuscript. Do not list the names in a footnote on the title page.


Contributors who meet fewer than all four of the criteria in the Definition of Authorship section for authorship should not be listed as authors, but they should be acknowledged in the Acknowledgment section.


Changes in authorship after acceptance are strongly discouraged, but the editorial leadership recognizes that in extraordinary circumstances, may be required. The Journal’s policy is as follows:

  1. A request to alter authorship must be made in writing from the corresponding author to the Editor-in-Chief, with a detailed explanation for the request, and the names and affiliations of the authors requiring addition and/or deletion.
  2. The editorial leadership will determine if the request is reasonable, valid, and warranted.
  3. Further information and/or documentation may be requested.
  4. Authorship may be altered after acceptance of a paper with the written approval of all authors named on the manuscript, as well as the individual(s) being added and/or deleted. The Publisher can provide a form for this, if needed.
  5. Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author.
  6. There is a one-year post-publication statute of limitation on requests for alterations in authorship.
  7. The Editor-in-Chief reserves the right to deny requests to alter authorship after acceptance of a manuscript.


  1. Competing Interests. A competing interest exists when an individual (or the individual’s institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  2. Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  3. Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  4. Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  5. Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.


In the event an error is discovered after publication of an article, the corresponding author should submit the correction in writing to the editorial office for consideration. Changes in author affiliations or contact details due to relocation are not permitted after publication.

Corrections to meeting abstracts will be made only to the online version. The Journal does not issue formal correction statements for corrections to meeting abstracts, regardless of the nature of the correction. 


The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are anonymous to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will officially retract the paper from the Journal and the scientific record by issuing a formal Retraction Notice. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential. 


Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI). Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  • Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.
  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
  • Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.
  • Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.


Autism in Adulthood is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to acceptance. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content compared to work previously published by authors, self-plagiarism can infringe upon a publisher’s copyright. To avoid plagiarism, be sure to cite all published works. 



Upon acceptance of any manuscript, all authors will receive an email with detailed instructions and a unique, author-specific link to access and complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications. FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION. The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright. Copyright forms may also be completed by logging in to the system using an author’s credentials. After logging on, click on Author Center and complete the forms located under “Manuscripts I Have Coauthored.”

Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc., unless alternate arrangements are made prior to publication, including CC-BY licensing (see below). By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.


Autism in Adulthood is fully NIH-, HHMI-, RUCK, and Wellcome Trust-compliant. 


Our open access publishing solutions allow you to comply with the open access policies of your institution, government, and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK) or Howard Hughes Medical Institute (HHMI), you can find more information below:

  • HHMI and NIH Public Access Policy – In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final paginated version of the published article to PubMed Central (PMC) on behalf of the authors after a 12-month embargo period. Authors need not take any action. This service is provided free of charge. Authors who wish to remove the 12-month embargo period are encouraged to consider publishing with Open Option.
  • Wellcome Trust Policy – To easily comply, you can choose to have your article published open access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the Wellcome Trust.
  • Research Councils UK (RUCK) – To easily comply, you can choose to have your article published Open Access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the RUCK.


Autism in Adulthood is a subscription-based peer-reviewed journal with Open Access options. Creative Commons CC-BY and CC-BY-NC licensing is available for any article published as Open Access for a standard fee of $3,200.00 USD. Please contact our Open Access Manager to order Open Access for your article. For more information about Open Access publishing, please visit our Liebert Open Access website. 


Upon submission of a manuscript, you will have an opportunity to enter funding/grant information. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata. The entered information should include funder names, funder IDs (if available), and associated grant numbers. (See for a listing of more than 13,000 international funding agencies.) 


•    There are no submission fees to the Journal.
•    There are no page charges for the Journal.
•    The Journal will publish color photographs, with a subsidy from the author. Costs are dependent upon the number of figures within a paper. For details, contact our Author Benefits administrator.
•    Open Access and Creative Commons licensing options are available. Contact our Open Access Manager for more information.
•    For pricing and purchasing reprints, contact our Reprints Manager. 


When reproducing copyrighted material such as figures or tables, the author(s) must obtain permission from the original copyright and/or publisher and submit it concurrently with the manuscript. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote to a reprinted table or the legend of a reprinted figure should read, “Reprinted by permission from Jones et al.” and list the appropriate reference. All permissions must be supplied at the time of submission. Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources. 


Reprints may be ordered by following the special instructions that will accompany the page proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is published will be charged at a substantially higher rate.


Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Your article will be easily searchable on Google, Google Scholar, and other search engines.


Autism in Adulthood is owned by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801; Tel: 914-740-2100; Email:; Website:

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.